Make hope abound.

We started Zitra to make medicines that really matter.

We don't follow crowds, chase fads, or pursue me-too drugs.

We leverage non-invasive “Trojan horse” brain delivery technology and mRNA engineering to develop life-changing medicines for patients suffering from terrible brain diseases.

Read more about our programs below.

    • GM2 Gangliosidosis (Tay-Sachs & Sandhoff Diseases)
      [Modality: mRNA, Genetic Target: HEXA/HEXB]

    • Lesch-Nyhan Syndrome
      [Modality: mRNA, Genetic Target: HPRT1]

    • Gaucher Disease Type 2 and 3
      [Modality: mRNA, Genetic Target: GBA1]

    • Alzheimer's Disease
      [Modality: Undisclosed, Genetic Target: Undisclosed]

    • GBA1-associated Parkinson's Disease
      [Modality: mRNA, Genetic Target: GBA1]

    • Traumatic brain injury (TBI)
      [Modality: mRNA, Genetic Target: Undisclosed]

To join our mission or learn more about our work, email us at hello@zitra.co.